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Abstract
Background: Stem cells of intensely regenerative tissues are susceptible to cellular damage. Although the response
to this process in hematopoietic stem cells (HSCs) is crucial, the mechanisms by which hematopoietic homeostasis
is sustained are not completely understood. Aging increases reactive oxygen species (ROS) levels and inflammation,
which contribute to increased proliferation, senescence and/or apoptosis, leading to self-renewal premature
exhaustion. In this study, we assessed ROS production, DNA damage, apoptosis, senescence and plasticity in young,
middle and aged (2-, 12- and 24-month-old, respectively) C57BL/6 J mice.
Results: Aged HSCs showed an increase in intracellular superoxide anion (1.4-fold), hydrogen peroxide (2-fold),
nitric oxide (1.6-fold), peroxynitrite/hidroxil (2.6-fold) compared with young cells. We found that mitochondria and
NADPHox were the major sources of ROS production in the three groups studied, whereas CYP450 contributed in
middle and aged, and xanthine oxidase only in aged HSCs. In addition, we observed DNA damage and apoptosis in
the middle (4.2- and 2-fold, respectively) and aged (6- and 4-fold, respectively) mice; aged mice also exhibited a
significantly shorter telomere length (−1.8-fold) and a lower expression of plasticity markers.
Conclusion: These data suggest that aging impairs the functionality of HSCs and that these age-associated
alterations may affect the efficacy of aged HSC recovery and transplantation.
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Background
Stem cells are important for the maintenance of func-
tional tissues and organs and have the abilities to self-
renew and replace damaged cells [1]. However, this
finely tuned regulatory system may become altered with
aging [2]. In fact, recent studies have suggested that the
ability to successfully regenerate cells/tissues is gradually
lost with aging, as justified by multiple physiological
changes at the molecular, cellular, organ, and system
levels that occur via mechanisms that are not fully
understood [3]. Therefore, the mechanisms that lead to
biochemical and cellular age-related alterations in the
most primitive cells of hematopoietic system are under
investigation in some laboratories.
It is well known that hematopoietic stem cells (HSCs)
from aged donor mice have negative effects on stem-cell
homing and engraftment [4], are more easily mobilized
into the peripheral blood [5] and are therapeutically less
efficient [6]. Although some researchers have highlighted
the impact of aging on HSCs, the molecular events that
trigger the biology of aging remain unclear. In both mice
and humans, researchers have profiled the expression of
genes involved in genomic integrity and transcriptional
regulation demonstrating that the direct or epigenetic
modulation of these genes (e.g. p53, p66shc, FOXO3,
SIRT1, NF-κB) are consequence of high levels of reactive
oxygen species (ROS) in different diseases [7, 8]. For ex-
ample, it is known that high ROS can inhibit SIRT1 and* Correspondence: smeyrelles@pq.cnpq.br1Laboratory of Translational Physiology, Health Sciences Center, Federal
University of Espirito Santo, Vitoria, Brazil
Full list of author information is available at the end of the article
© 2015 Porto et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Porto et al. Journal of Biomedical Science  (2015) 22:97 
DOI 10.1186/s12929-015-0201-8
activate p53, contributing to apoptosis and senescence
[9–11]. In addition, it was recently demonstrated that
high ROS causes mitochondrial disruption, leading to
cytochrome c release and the subsequent activation of a
protease cascade [12] with consequent impairment of
protein repair pathways [13], culminating in loss of cell
integrity, DNA fragmentation and premature exhaustion
of self-renewal of these cells [14–16].
Interestingly, while ROS at physiological levels is gen-
erated mainly by mitochondrial source and secondary by
NADPH oxidase (NAPHox) [14, 17, 18], high ROS pro-
duction can be derived from other additional sources
such as cytochrome P450 (CYP450), xanthine oxidase
(XO), lipoxygenases and uncoupling nitric oxide syn-
thase [16, 19–21], which when associated to a reduction
of antioxidant activities (e.g. SOD, CAT and GPx) [22]
leads to a “vicious cycle” of self-inflicted damage. Thus,
since oxidative stress might be considered an important
cause of bone marrow HSC dysfunction during the aging
process [16], the contributions of different pathways in
ROS production deserves to be more explored in this
HSC source.
In this study, we analyzed the effects of biological
aging on the molecular pathways of ROS production in
HSCs. Our findings show a novel age-dependent decline
in HSC function that correlates with increased ROS pro-
duction by different sources. These data suggest that
aging impairs the functionality and quality of HSCs, af-




Experiments were performed in young, middle and aged
(2-, 12- and 24-month-old, respectively) male C57BL/6 J
(C57) mice that were bred and maintained in the Labora-
tory of Translational Physiology animal facility (Vitoria,
ES, Brazil). The mice were fed a standard chow diet and
provided water ad libitum. Animals were housed in indi-
vidual plastic cages with controlled temperature (22 °C)
and humidity (60 %) and were exposed to a 12/12 h light–
dark cycle. Mice were euthanized with sodium thiopental
overdose (100 mg/kg, intraperitoneal injection). Care and
use of laboratory animals were in accordance with Na-
tional Institutes of Health (NIH) guidelines. All experi-
ments were conducted in compliance with the guidelines
for biomedical research, as stated by the Brazilian Societies
of Experimental Biology, and were approved by the Insti-
tutional Ethics Committee - Emescam College of Health
Sciences (CEUA-EMESCAM 014/2011).
Blood and bone marrow samples
The mice were euthanized, blood was collected for a
complete blood count (CBC) and the femurs and tibias
were removed. The marrow cavities were flushed with ster-
ile Dulbecco’s Modified Eagle Medium (DMEM Sigma-
Aldrich, Saint Louis, MO, USA). Cell suspension were
placed in culture with DMEM supplemented with 20 %
FBS (Gibco Life Technologies, São Paulo, SP, Brazil), 100
U/mL penicillin and 100 μg/mL streptomycin. An aliquot
of the cell suspension was counted on a hemocytometer
chamber. To enrich the hematopoietic progenitor cell frac-
tion, lineage committed cells were depleted. The cell sus-
pension (1-2×107 cells/mL) was labeled with the Mouse
Hematopoietic Stem Cell Enrichment Set containing anti-
bodies against CD3e (CD3 ε chain), CD11b (Integrin αM
chain), CD45R/B220, Ly-6G and Ly-6C (Gr-1), and TER-
119/Erythroid Cells (Ly-76) (BD Biosciences, San Diego,
CA, USA) for 15 min on ice. Subsequently, the cell suspen-
sion was incubated with magnetic nanoparticles at 6 - 12 °
C for 30 min. The cell suspension was loaded into an
Imagnet column (BD), and the unlabeled cells that passed
through the column were collected (Lin− fraction). The
column was then washed twice with 1 mL of buffer, and
the remaining Lin− cells were collected.
Cell staining
To identify stem/progenitor hematopoietic stem cell, Lin−
cells were stained with monoclonal antibodies conjugated
to different fluorochromes. These antibodies included: Sca-
1(BD), CD133 (eBioscience, San Diego, CA, USA), c-kit
(BD), Thy-1lo (BD) and the appropriate isotype controls.
HSCs were defined as c-kit+, Thy-1lo, Lin−, Sca-1+ (KTLS)
and CD133+ in this study. No differences were found in
the fluorescent intensity among the groups (data not
shown). The expression of the intracellular pluripotency
markers was also analyzed by labeling cells with three
fluorochrome-conjugated antibodies: Oct3/4, Sox-2 and
Nanog (BD), according to the manufacturer’s instruction.
Cell cycle analysis
Cell cycle distribution was evaluated by flow cytometry.
Prior to staining, 1×106 cells were washed with phos-
phate buffered saline (PBS). The cells were treated with
50 μL of RNase (1 mg/mL) and 100 μL propidium iodide
(PI, 400 μg/mL) (Sigma-Aldrich) for 30 min at 37 °C in
the dark. The fluorescence of the stained cells was ana-
lyzed by flow cytometry, and the relative percentage of
gated cells in each cell cycle phase was determined [23].
Measurement of cytokine levels
Cytokine (IL-12p70, TNF, IFN-y, IL-10 and IL-6) levels
were measured systemically and locally by flow cytome-
try using a Cytometric Bead Array – Mouse Inflamma-
tion Kit, according to the manufacturer’s instructions
(BD). For these analyses, a typical forward and side scat-
ter gate was set to exclude aggregates; a total of 5000
events in the gate were analyzed using FACSCanto II and
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FACSDiva Software (BD). The samples were quantified by
comparison with standard curves of recombinant mouse
cytokines using FCAP Array software (BD). The results
were expressed as pg/mL.
Measurement of intracellular ROS and hROS
ROS analysis was performed by flow cytometry as previ-
ously described [15]. Dihydroethidium (DHE, 160 μM)
and 2’,7’-dichlorofluorescein diacetate (DCF, 20 mM)
were added to the cell suspension (106 cells) and incu-
bated at 37 °C for 30 min in the dark to estimate the
intracellular superoxide (•O2
−) or hydrogen peroxide
(H2O2) concentration, respectively. The measurement of
nitric oxide (NO) was performed as previously described
[24]. Briefly, the NO-sensitive fluorescent probe 4,5-dia-
minofluorescein-2/diacetate (DAF, 2 μM) was added to
cell suspension (106 cells) and incubated at 37 °C for
180 min in the dark. Highly reactive oxygen species
(hROS), such as hydroxyl radical and peroxynitrite, were
selectively detected by 2-[6-(4′-hydroxy) phenoxy-3H-
xanthen-3-on-9-yl] benzoic acid (HPF). The cells were
then washed, resuspended in PBS and analyzed by flow
cytometry (FACSCanto II). The data were acquired using
the FACSDiva software (BD) and overlay histograms were
analyzed using FCS Express software trial (De Novo). For
the quantification of DHE, DCF, DAF and HPF fluores-
cence, the samples were acquired in duplicate and 10,000
events were used for each measurement. The cells were
excited at 488 nm; DHE fluorescence was detected using a
585/42 bandpass filter, and DCF/DAF/HPF fluorescence
was detected using a 530/30 bandpass filter. The data are
expressed as the median fluorescence intensity.
Identification of oxidative stress sources
The cells were incubated in the presence of the inhibi-
tors based on previous experiments [25] and ROS pro-
duction was analyzed using DHE and DCF probes
following established protocols from our laboratory [23].
The inhibitor concentrations were as follows: 100 μM
clotrimazole for 10 min, 600 μM apocynin for 10 min,
100 μM allopurinol for 10 min, and 1 μM Carbonyl
cyanide 3-chlorophenylhydrazone (CCCP) for 45 min.
To investigate a decline in the capacity of the antioxi-
dant enzyme system, 3 inhibitors were used: superoxide
dismutase (SOD) through 500 μM sodium diethyldithio-
carbamate (DDC) for 16 h, CAT through 20 mM 3-
Amino-1,2,4-triazole (3-AT) for 2 h and glutathione per-
oxidase (GPx) through 50 μM mercaptosuccicinic acid
for 2 h.
Measurement of oxidized DNA by alkaline comet assay
DNA damage was assessed using alkaline single cell gel
electrophoresis (the alkaline comet assay), following
established protocols from our laboratory [23]. In brief,
histological slides were pre-coated with 1.5 % normal
melting point agarose in PBS in a water-bath at 65 °C.
Subsequently, 20 μL of the cell suspension was embed-
ded in 100 μL of 0.5 % low melting point agarose in PBS
at 37 °C and spread on agarose-precoated slides using
coverslips. Then, the slides were placed in an electro-
phoresis chamber filled with freshly prepared alkaline
buffer (300 mM NaOH, 1 mM EDTA, pH > 13) for 40 min
at 4 °C, and electrophoresed at 300 mA and 20 V for
30 min. Subsequently, the slides were neutralized with a
0.4 M Tris buffer (pH 7.5) for 5 min, washed with cold dis-
tilled water and allowed to dry at room temperature for
1 h. Migration of the DNA fragments towards the anode
creates a comet ‘tail’ visualized by staining with ethidium
bromide (20 μg/mL, Sigma-Aldrich). Immediately after-
wards, images were obtained at a magnification of 200x
using a fluorescence optical microscope (Nikon Eclipse Ti,
Melville, NY, USA) equipped with excitation (510–550 nm)
and barrier (590 nm) filters. The coded images were ac-
quired using a CCD camera (Nikon) and analyzed using
the CASP program (public domain) to determine the %
DNA in tail and the tail moment parameters.
Determination of cell viability, apoptosis and necrosis
Apoptotic HSCs were quantified by annexin V-FITC and
propidium iodide (PI) double staining using the annexin
V-FITC apoptosis detection kit (BD). In brief, the cells
were washed twice with PBS and adjusted to 500 μL in
binding buffer (5×105 cells). Then, annexin V–FITC and
PI were added to cell suspension, and the cells were gen-
tly vortexed. The cells were then incubated for 15 min at
room temperature (25 °C) in the dark. Finally, the cells
were analyzed by flow cytometry using a FACSCanto II
(BD). Necrotic cells were defined as annexin V−/PI+, late
apoptotic or secondary apoptotic were defined as annexin
V+/PI+, and annexin V+/PI− cells were recognized as early
or primary apoptotic cells [23].
Measurement of telomere length
Telomere length was measured with the telomere PNA
kit/FITC (DAKO Denmark, Glostrup, DK). In brief, the
sample DNA was denatured for 10 min at 82 °C either
in the presence of hybridization solution without probe
or in hybridization solution containing a fluorescein-
conjugated PNA telomere probe. The hybridization then
took place in the dark at room temperature overnight,
followed by two 10-min post-hybridization washes with
a wash solution at 40 °C. The sample was then resus-
pended in the appropriate buffer for further analysis by
flow cytometry. The DNA Staining Solution included in
the kit was used for the identification of G0/1 cells. After
flow cytometry analysis, the data obtained were used to
determine the relative telomere length (RTL). The RTL
value was calculated as the ratio between the telomere
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signal of each sample and the control cells (1301 cell
line, European Collection of Cell Cultures) with correc-
tion for the DNA index of G0/1 according to manufac-
turer’s instructions.
Assessment of lysosomal content
Quantification of the cellular lysosomal mass was carried
out by flow cytometry. The cells were stained with acrid-
ine orange (AO) as described before [26]. Briefly, 0.2 mL
of cell suspensions were gently admixed with a solution
containing 1 mg/ml of AO (Invitrogen, Eugene, OR),
1 mM EDTA-Na, and 0.15 M NaCl in phosphate-citric
acid buffer (pH 7.4) was added for 10 min. The photo-
multiplier settings on the flow cytometer were adjusted
to detect the green fluorescence signal of AO (mostly
due to nucleic acid staining) on the 530/30 nm bandpass
filter and the orange fluorescence signal (due to lyso-
somal staining) on the 585/42 nm bandpass filter.
Senescence associated β-galactosidase (SA-β-gal) activity
analysis
HSC senescence activity was determined using a SA-β-gal
staining kit (Sigma-Aldrich) according to the manufac-
turer’s instruction. Briefly, the cells were washed with PBS
and fixed in 2 % formaldehyde–0.2 % glutaraldehyde. Then,
the cells were washed and incubated at 37 °C overnight
with fresh SA-β-gal staining solution (1 mg 5-bromo-4-
chloro-3-indolyl- β -D-galactopyranoside [XGal] per mL,
40 mM citric acid–sodium phosphate [pH 6.0], 150 mM
NaCl, 2 mM MgCl2, 5 mM potassium ferrocyanide, 5 mM
potassium ferricyanide). Senescent cells were identified as
blue-stained cells by standard light microscopy, and a total
of 1000 cells were counted in random fields on a slide to
determine the percentage of SA-β-gal–positive cells.
Photography of cells was performed on microscope
(Nikon Eclipse Ti, Melville, NY, EUA) equipped with
CCD camera (Nikon).
Statistical analysis
Data are presented as mean ± SEM. The normality of the
variables was evaluated using the Kolmogorov–Smirnov
test. Analyses of variance (ANOVA) were performed using
Graphpad Prism 6 software followed by Tukey’s multiple
comparison tests to establish statistical significance be-
tween experimental groups at the p <0 .05 (*) level.
Results
Aging stimulates cell cycling and myeloid skewing
To evaluate the impact of aging on HSCs (KTLS/CD133+),
we determined the number of cells and proliferation by cell
cycle analysis (Table 1) and complete blood count (CBC)
(Table 2). We observed a 3.3-fold increase in the number of
HSCs during the lifespan (p < 0.05) when comparing aged
and young mice. The cell cycle profile revealed an increased
proliferation rate in HSCs from aged mice compared with
young and middle mice, indicating that more HSCs began
cycling with age (Table 1). Moreover, we observed a change
in the number of mature hematopoietic cells in the periph-
eral blood. The increased engraftment of the myeloid
lineage (1.6-fold, p < 0.05) and loss of lymphopoiesis sup-
port (−1.3-fold, p < 0.05) by aged HSCs was observed com-
pared with young mice (Table 2). These data suggest that
Table 1 Effects of aging on body weight, hematopoietic stem




Body weight (g) 28 ± 1 29 ± 1 34 ± 1*
Hematopoietic stem cells (x106) 1.7 ± 0.2 4.3 ± 1 5.6 ± 1#
Cell cycle (%)
Sub G0 1 ± 0.2 4 ± 0.2 5 ± 0.5*
G0/G1 81 ± 2.6 75 ± 2.3 66 ± 2.9*
S/G2/M 18 ± 2.5 21 ± 2.6 29 ± 2.8*
Myeloid Cytokines (pg/mL)
IL-6 23 ± 2 28 ± 2 63 ± 8*
TNF 111 ± 7 122 ± 7 227 ± 27*
IL-12p70 141 ± 11 142 ± 10 203 ± 14*
Lymphoid Cytokines (pg/mL)
IFN-γ 3.2 ± 0.5 3.3 ± 0.6 4.1 ± 0.3
IL-10 181 ± 17 164 ± 16 149 ± 8
Values are means ± SEM for six to 11 animals per group. *p < 0.05 vs young
and middle age; # p < 0.05 vs young (one-way ANOVA)




Cell Blood Count (CBC)
Red blood cell number (106/ mm3) 4.4 ± 1 7.3 ± 0.2# 7.0 ± 0.3#
White blood cell number (103/ mm3) 2.9 ± 0.4 2.8 ± 0.3 5.3 ± 1
Myeloid (%) 24 ± 4.3 27 ± 4.1 40 ± 4.2*
Lymphoid (%) 76 ± 4.3 73 ± 4.1 60 ± 4.2*
Myeloid Cytokines (pg/mL)
IL-6 256 ± 30 348 ± 34 543 ± 37*
TNF 265 ± 19 398 ± 17 588 ± 80*
IL-12 153 ± 12 187 ± 8 172 ± 16
Lymphoid Cytokines (pg/mL)
IFN-γ 69 ± 1.5 77 ± 2.3 75 ± 3.3
IL-10 516 ± 34 586 ± 22 573 ± 19
Values are means ± SEM for six to 11 animals per group. *p < 0.05 vs young
and middle age; #p < 0.05 vs young (one-way ANOVA)
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the natural aging process causes increased proliferation
rates of HSCs, lymphoid senescence and myeloid skewing.
Inflammatory cytokines are increased during aging
Aging is characterized by an increase in the levels of
pro-inflammatory markers, which may contribute to im-
paired bone marrow HSC function and result in a state
of chronic inflammation or “inflamm-aging” [27]. The
pro-inflammatory cytokines IL-12p70, IL-6 and TNF can
act as growth factors to stimulate proliferation. The data
obtained by flow cytometry showed both locally (Table 1)
and systemically (Table 2) increased levels of myeloid
pro-inflammatory molecules in aged mice compared
with young mice. However, no differences were found in
the concentrations of IL-10 and IFN-γ, which could be
expected to counteract the effects of pro-inflammatory
cytokines.
ROS production are augmented during aging
Based on previous experiments showing that high levels
of ROS represent a key mechanism for intrinsic HSC
dysfunction [14, 28], we evaluated the intracellular ROS
levels in HSCs in the three groups of animals. As illus-
trated in the top panel and summarized in the bar
graphs of Fig. 1, we observed a clear age-related increase
in ROS production. Specifically, our data showed signifi-
cant increases in the levels of •O2
− and NO only in aged
HSCs (1.4- and 1.6-fold, respectively) and augmentation
in the H2O2 and in the hROS levels in both middle (1.2-,
1.4-fold, respectively) and aged (2-, 2.6-fold, respectively)
compared with young HSCs (p < 0.05). This imbalance
between ROS production and degradation could lead to
genomic instability and, consequently, permanent
changes in the genetic material.
Sources of ROS and antioxidant enzyme capacity in HSCs
Considering that little is known about which pathways
are involved in ROS production by HSCs and the stimuli
of cell intrinsic alterations that trigger HSC aging, we
evaluated the relative contributions of different path-
ways, which could lead to augmented ROS production
and/or the loss of antioxidant capacity. To achieve our
goal, we blocked the main sources of ROS and measured
the fluorescent intensities of DHE and DCF. Figure 2
shows the average changes in pro-oxidative and anti-
oxidative pathways in the three different age groups. We
observed that in young animals the mitochondria and
NADPHox represented the major pro-oxidative sources
in HSCs. In the middle group, CYP450 contributed sig-
nificantly in addition to these two sources. In aged
HSCs, all of the investigated sources in this study ac-
tively contributed to the high levels of ROS production
(NADPHox, mitochondria, CYP450 and XO). In a separ-
ate set of experiments, to investigate the involvement of
the anti-oxidative pathways in the process of aging, we
blocked three important enzymes: SOD, CAT and GPx.
Our data showed high activity of these three anti-
oxidative pathways in HSCs from young animals. In con-
trast, HSCs from middle mice exhibited a significant im-
pairment in CAT and GPx function, which was more
greatly impaired in cells from aged mice that showed re-
duced activity in the entire system compared with HSCs
from young mice.
Fig. 1 ROS generation and oxidative stress pathways are involved in
aging. A- ROS production was assessed by DHE, DCF, DAF and HPF
staining. Top panel shows representative images of HSCs; the aged
group presented change in the number of cells that stained
ROS-positive compared with young animals. Bar graph shows
the difference on MFI of the ROS measured by flow cytometry
among the groups. Values are means ± SEM, *p < 0.05 vs. young.
#p < 0.05 vs. middle
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DNA damage and apoptosis increases with aging
In this study, we used the alkaline comet assay to evalu-
ate DNA damage, expressed by the percentage of DNA
in the tail which represents the number of fragments
that migrated during electrophoresis, and the comet tail
moment, which is an index of both the migration of the
genetic material and the relative amount of DNA in the
tail [15, 23, 24]. Figure 3a shows a remarkable increase
in DNA fragmentation in HSCs from middle (4.2-fold)
and aged (5.9-fold) mice compared with young mice
in the tail moment parameter (p < 0.05). Moreover,
HSCs from middle and aged mice showed more DNA
Fig. 2 Identification of the main sources of ROS production and antioxidant enzyme capacity by oxidative stress pathway analysis. Bar graphs
show the effect of different oxidant proteins inhibitors on ROS production and antioxidant proteins inhibitors on ROS reduction. ROS levels were
analyzed by DHE and DCF fluorescence intensity. Unshaded bars represent basal ROS levels, and shaded bars show ROS levels after blockade.
Abbreviations: NADPH oxidase (NADPHox), xanthine oxidase (XO), cytochrome P450 (CYP450), superoxide dismutase (SOD), catalase (CAT),
gluthatione peroxidase (GPx). Values are means ± SEM, *p < 0.05 vs. matched basal
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in the tail (2.8- and 3.3-fold, respectively) compared
with HSCs from young mice (p < 0.05). High ROS
levels are frequently associated with an increase in
DNA fragmentation and, consequently, more apop-
tosis [15, 23, 24].
An analysis of apoptosis can be used to assess aging and
survival in the hematopoietic compartment. Figure 3b
shows that cell viability was reduced throughout the life
span. Middle and aged mice showed a significant increase
in the percentage of cells in early apoptosis (10 and 14 %,
respectively), defined by annexin-V+/PI−, compared with
young mice (4 %). In contrast, only aged HSCs demon-
strated a remarkable change in late apoptosis (4 %), defined
by annexin-V+/PI+, compared with young (0.1 %, p < 0.05)
and middle (0.3 %, p < 0.05) mice. Necrosis, defined as
annexin-V−/PI+, increased in middle and aged HSCs (~5 %)
compared with the young group (~1.5 %, p < 0.05). The in-
crease in ROS levels during the life span was positively cor-
related with the increase in apoptosis (Fig. 3c). These data
suggest that increased ROS production in aged HSC may
be involved in the apoptotic signaling pathway.
Cellular senescence increases during the aging process
To investigate the effects of aging on HSCs, we per-
formed the SA-β-gal, which is one of the most widely
used biomarkers for aging cells [15]. As illustrated in
Fig. 4a (, top panel), the cytoplasm of senescent cells stains
blue allowing easy identification. The aging process in-
duced a remarkable increase in the percentage of SA-β-gal
positive HSCs (~10 %) compared with young and middle
(~1.5 %) animals, as summarized in the bar graph (Fig. 4a).
To investigate senescent characteristics, we evaluated
telomere length and lysosomal mass. Telomere shortening
limits the cell proliferation capacity to a finite number of
cell divisions. The accumulation of DNA damage and telo-
mere dysfunction can contribute to the decline of stem
cell maintenance and function [8]. In the present study,
the HSC telomere length was shortened in approximately
80 % (p < 0.05) of aged and 23 % of middle mice compared
with young mice, suggesting reduced telomerase activity
in aged mice (Fig. 4b). We also observed a remarkable in-
verse correlation between the intracellular ROS levels and
the RTL in HSC from middle and aged (r = −0.9, p < 0.05)
mice (Fig. 4b, top panel). Then, we investigated whether
the senescence could also result from changes in lyso-
somal mass. Our data indicated an increased side scatter
(SSC) profile in the HSC aged group, which is an indicator
of cellular granularity (data not shown). Finally, we also
performed a flow cytometry analysis of AO fluorescence,
and the aged group showed a dramatic increase of ~90 %
compared to middle and young mice (Fig. 4c). Therefore,
the increase in both SSC and AO fluorescence is indicative
of augmented lysosomal content in aging cells [26]. More-
over, the increase in AO fluorescence correlated closely
with the increase in ROS levels observed in the aged
group (Fig. 4c, top panel). Altogether, these data indicate
that high ROS levels can trigger senescence.
Cell fate and self-renew are impaired in HSC bone marrow
niche
ROS-induced DNA damage is associated with genomic
instability and, consequently, the loss of regenerative
capacity, self-renewal dysfunction and cell cycle arrest of
HSCs. We tested the hypothesis that the high ROS levels
Fig. 3 Augmented ROS leads to DNA damage and apoptosis of HSCs during aging. a The top panel shows typical photographs of comets with
higher DNA fragmentation in the middle and aged groups. Bar graphs show the percentage of DNA in the tail and the tail moment. b Table shows
the average percentage of viable cells, early apoptosis, late apoptosis and necrosis detected by annexin-V and PI staining. c Correlation between
intracellular ROS levels and apoptosis. Values are means ± SEM, *p < 0.05 vs. young. #p < 0.05 vs. middle
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observed in aged HSCs may influence the expression
profile of the Oct-3/4, Sox-2 and Nanog transcription
factors (ONS) derived from young, middle and old bone
marrow. As illustrated in Fig. 5 (bottom panels), our data
showed that ONS expression was significantly decreased in
aged HSCs compared with the middle and young groups
(Oct-3/4: −50 %; Sox-2: −30 %; Nanog: −23 %, p < 0.05).
This finding in aged HSC supports the idea that the
loss of the regenerative capacity and self-renewal of
these cells is correlated with the high ROS levels
(Fig. 5, top panels).
Discussion
In the present study, we investigated age-related changes
in HSC function and found an increase in the number of
cells, prevalence of cells in the cycling phases, and a
Fig. 5 Pluripotency markers are downregulated by augmented ROS production during aging. The top panels show the correlation between intracellular
ROS and ONS transcription factors. Bar graphs show the percentage of positive ONS cells. Values are the means ± SEM, *p< 0.05 vs. young. Abbreviation:
Oct-3,4/Nanog/Sox-2 transcription factors (ONS)
Fig. 4 Aging leads to molecular and cellular senescence of HSCs. a The top panel shows typical senescent cells with blue cytoplasm (arrow) and
the bar graph shows the percentage of positive cells quantified by cell counting (bottom panel). b Top panel shows the correlation between
intracellular ROS levels and acridine orange fluorescence. The bar graph shows the median fluorescence intensity of acridine orange (bottom
panel). c The top panel shows the correlation between the intracellular ROS levels and relative telomere length (RTL). Bottom panel show the
percentage of RTL. Values are means ± SEM, *p < 0.05 vs. young
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myeloid skewing of committed hematopoietic cells that
was induced by the high levels of pro-inflammatory
cytokines. The novel finding of this study was the
characterization of the major sources of ROS produc-
tion in HSCs, which occurred in an aging-dependent
manner. Our data show that the consequences of
ROS accumulation in HSCs include genotoxic dam-
age, apoptosis, senescence and the loss of multipo-
tency of these aged cells.
HSC number, cell cycle, cbc and cytokines
Previous experimental and clinical data have shown that
aging promotes the increase of HSCs number in the bone
marrow [29, 30]. In our study, we also observed high HSC
proliferative activity that was associated with aging, which
in turn was associated with an approximately 10 % in-
crease in the number of cells in the S/G2/M phases of cell
cycle in aged mice. Initially, we speculated that this aug-
mented proliferative activity might be a fundamental com-
pensatory mechanism to maintain the lymphopoiesis and
self-renewal functions of these HSCs. However, we de-
tected that the aging process resulted in a decrease of lym-
phopoiesis and in myeloid skewing. Moreover, our data
revealed a change in CBC and an increase in the myeloid-
derived cytokine levels (IL-6, TNF, IL-12), without alter-
ations in the lymphoid-derived cytokines (IFN-γ, IL-10).
Our data are in accordance with other studies, which
showed that aged HSC are more actively cycling and pref-
erentially differentiating toward myelopoiesis [7, 8]. Be-
cause oxidative stress is involved in the induction of
systemic and local myeloid cytokines production [31] and
because HSCs are extremely sensitive to the extensive ac-
cumulation of ROS [32], we used flow cytometry to inves-
tigate whether excessive ROS production could contribute
to the amplification of myeloid skewing over time.
ROS overproduction in aged HSCs
It is known that bone marrow HSCs with low ROS activ-
ity exhibit normal lymphoid production, which allows
them to maintain their quiescence and self-renewal po-
tential [33]. Some mechanisms appear to protect HSC
from oxidative stress, such as antioxidant enzyme status
and preferential anaerobic glycolysis instead of oxidative
phosphorylation to ATP production [34]. In our study,
we observed that the protection against this oxidative
stress was lost during the aging process; we detected
higher levels of ROS production in aged HSCs with differ-
ent probes. Aged mice exhibited high levels of all mole-
cules, as indirectly measured by flow cytometry: •O2
−,
H2O2, NO, including the strongest oxidant produced in
biological systems: •ONOO− and •OH−. These data com-
plement and strengthen those obtained in previous studies
regarding ROS detection [28, 35] and highlight the pos-
sible contribution of oxidative stress for myeloid skewing
over time.
Sources of ROS and antioxidant enzyme activity
Several studies have demonstrated that all cell types pro-
duce ROS in multicellular organisms [36, 37]; although
the mitochondria has traditionally been considered the
main source of intracellular ROS [38], other enzymatic
systems also contribute to ROS generation, including
NADPHox [39], XO, cyclooxygenases, CYP450 complex,
nitric oxide synthase and lipoxygenases [40]. However,
prior to the present study, little was known about which
sources of ROS are involved in aging and, more specific-
ally, which pathways are involved in bone marrow HSCs.
For this purpose, we tested the hypothesis that at least
four main sources could be involved in ROS overpro-
duction during the life span. The data obtained through
the use of specific pharmacological blockers confirmed
Fig. 6 Scheme showing multiple age-related factors regulating hematopoietic stem cell function. Alterations in HSC function observed in aging:
generation and main types of damage induced by ROS, different mechanisms of oxidative cellular/molecular damage and the potential role of
antioxidants on HSC fate during the aging process. Lines with arrowhead indicate stimulation and lines with crosshead indicate inhibition. A line
with a double arrowhead indicates a normal condition. Abbreviations: hematopoietic stem cells (HSC), reactive oxygen species (ROS), NADPH oxidase
(NADPHox), cytochrome P450 (CYP450), xanthine oxidase (XO), lymphoid cells (L), myeloid cells (M), tumoral necrosis factor (TNF), interleukin-12p70 (IL-12),
interleukin-6 (IL-6)
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the idea that the mitochondria and NADPHox are the
major sources of ROS in young HSCs, as reviewed by
Urao and Ushio-Fukai [16]. However, in the present
study, we expanded the time-course, and our data re-
vealed a different profile for ROS sources. For instance,
CYP450 played a relevant role in both middle and aged
HSCs, and XO was an important source in aged HSCs.
The process of aging generates an “inflamm-aging” en-
vironment, in which higher levels of ROS may activate
inflammatory mediators and vice-versa [41]. We observed
different complexes contributing to an increase in oxida-
tive stress and the augmentation of local and systemic
pro-inflammatory cytokines. Our data are consistent with
those of other studies demonstrating that elevated ROS
activity in aged bone marrow has the ability to induce
local mediators of inflammatory production [31] and that
aging increases the systemic cytokine levels [33].
In relation to antioxidant enzymes, we observed that
in HSCs from middle mice, the SOD activity was pre-
served but the CAT and GPx were impaired, which
could explain the accumulation of H2O2 and the main-
tenance of •O2
− levels compared with young HSCs. Con-
versely, in aged HSCs, there was an impairment of all
three antioxidant enzymes, which may directly reflect
ROS augmentation. As a consequence of this process,
high intracellular ROS production may be involved in
cellular signaling and may regulate different mediators
[42]. Among them, the FoxO transcription factors ap-
pear to be critical mediators of the cellular responses to
oxidative stress, since the lack of FoxO subtypes in HSCs
down-regulates the expression of antioxidant enzymes
(such as SOD and CAT) and consequently leads to an
increase in ROS levels within the HSC compartment
[43]. Based on these data, we speculated that aging may
impair the expression of the FoxO family and conse-
quently diminish the anti-oxidative enzyme levels.
DNA damage and apoptosis
ROS are highly reactive and can oxidize nucleic acids,
proteins and lipids [23, 24]. We performed an alkaline
comet assay to assess single- and double-strand breaks
in DNA from young, middle and aged HSCs. Our data
showed a strong correlation among ROS production,
DNA damage and apoptosis. As expected, DNA frag-
mentation, cell death and ROS production were aggra-
vated in the aged HSCs. Our data are in agreement with
those of Rossi et al. [8], who investigated the HSC re-
serves and function in aged mice, which are deficient in
several genomic maintenance pathways, including nu-
cleotide excision repair, telomere maintenance and non-
homologous end-joining with elevated levels of apoptosis.
Moreover, Jang et al. [14] demonstrated that although low
levels of ROS are involved in the maintenance of quies-
cence in HSCs, higher levels of ROS contribute to greater
proliferation, senescence or apoptosis, which in turn lead
to the premature exhaustion of self-renewal in these cells.
We observed that high ROS production leads to the accu-
mulation of DNA damage. Cells in which the damage can
be repaired may continue through the cell-cycle, whereas
those that have suffered irreparable genotoxic oxidative
damage undergo apoptosis or cell-cycle arrest [44]. There-
fore, the causative role of augmented ROS production in
the loss of cell viability is substantiated by increased DNA
fragmentation. This is favored by an augmented cell pro-
liferation rate, suggesting that ROS can act as secondary
messengers to modulate multiple cell signaling pathways.
HSC senescence
Oxidative stress is a determining factor of cellular senes-
cence, a biologically active response that contributes to
tissue aging through at least two mechanisms [8, 45]:
first, intrinsically, through the inability to further prolif-
erate to replace tissues with new cells, and second, by
up-regulating genes that encode inflammatory cytokines,
growth factors and extracellular-matrix-degrading en-
zymes [45]. Then, we investigated the impact of aging
on cellular senescence using a SA-β-gal assay and AO
fluorescence, which indirectly reflects the lysosome mal-
function; when the property of autophagy is lost, the ly-
sozymes accumulate in the aging cells [26, 46]. In the
present study, we found that both the number of SA-β-
gal positive HSCs and AO fluorescence were increased
in aged mice. These results indicate that cell senescence
increases the level of β-galactosidase activity and lyso-
somal content in aged HSCs.
To confirm senescence using a second, well-established
procedure, we investigated the shortening of telomeres. In-
deed, dysfunctional telomeres have been found, in vivo, in
senescent cells, and the loss of telomerase function causes
the senescence and physiological impairment of many tis-
sues [45]. In our study, aged HSCs showed shorter telo-
meres than HSCs from the young group. However, it
should be noted that not all studies have detected the asso-
ciation between telomere shortening and senescence [35]
because cellular senescence may occur in an independent
manner [47]. Furthermore, a decline in autophagic cap-
acity caused by aging leads to an accumulation of damaged
mitochondria and, consequently, to an increase in ROS
production, which can stimulate the secretion of pro-
inflammatory cytokines and accelerate the aging process,
the so-called “inflamm-aging” condition [41]. Additionally,
in attempt to answer a possible question whether ROS
contributes directly to DNA damage and cellular senes-
cence, we designed a new in vitro protocol focused in this
issue. Briefly, we verified that a sub-lethal dose of H2O2 (at
100 μmol/L for 12 h) augmented the rate of sub-G0 cells
and SA-β-gal–positive cells (2-fold in relation to H2O2 at
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10 μmol/L) which was rescued by ascorbic acid pretreat-
ment (50 mg/mL) for 30 min (data not shown).
HSC ONS transcription factors
The control of cellular fating is a complex process in
which the cell must coordinate many different signals
[48]. Considering the importance of ROS in cellular sig-
naling and the regulation of gene expression, it is feas-
ible that ROS are involved in cell differentiation [42].
We next evaluated the age-related changes in cell
plasticity and self-renewal. The uniform expression of
hematopoietic markers (KTLS/CD133+ fraction: c-kit+
Thy-1loLineage−Sca-1+CD133+) in each group, as ob-
served in this study, indicates homogeneity in the iso-
lated bone marrow-derived HSC population and does not
necessarily correlate with plasticity. Conversely, the pro-
gressive loss of pluripotent transcription factors is indica-
tive of the age-related loss of multipotency. For instance, it
is well documented that the combinatorial transcription
factor interaction network of ONS is associated with pluri-
potency and stemness in embryonic stem cells [35]. Inter-
estingly, our results revealed age-related changes in the
ONS expression profile. Similarly, Assumda et al. [49]
found a decreased expression of ONS markers in bone
marrow-derived mesenchymal stem cells from old rats.
Moreover, a recent study showed stemness loss and lineage
commitment of multipotent populations induced by the in-
flammatory cytokine secretion of senescent-like cells [50].
Our data suggest that increased levels of intracellular ROS
diminish ONS positivity, as observed through the negative
correlation between ONS and ROS (Fig. 5). In accordance
with this hypothesis, recent studies have demonstrated the
importance of ROS in cell differentiation in the mouse and
human [51, 52] and that human embryonic stem cell pluri-
potency can be improved through reduced levels of ROS
[53]. Although the exact role of ROS in stemness has yet to
be clarified, it is now clear that redox homeostasis should
be strictly regulated to avoid HSC exhaustion.
Cell cycling and premature exhaustion
HSCs preferably remain quiescent in bone marrow, mak-
ing them especially susceptible to accumulation of DNA
damage, which contributes to the gradual decrease in
their function with age [54]. Genotoxic oxidative stress
causes loss of HSC self-renewal capability [55] since they
quit quiescence and then differentiate, preventing the
propagation of genetically unstable HSCs [56–59]. In re-
sponse to genotoxic oxidative stress, HSCs can undergo
extensive proliferation caused by increased levels of ex-
trinsic [60] and intrinsic [61] factors that play important
roles in determining HSCs fate. In addition, this process
could lead to HSC exhaustion and myeloid skewed dif-
ferentiation [14, 56, 62, 63].
The mechanisms involved in repair of DNA damage are
initiated when aged HSC re-enter the cell cycle [54, 64, 65]
and their fate could result in cellular dysfunction leading to
the homeostatic failure of bone marrow HSC pool [66–68].
It must be taken into account that augmented ROS produc-
tion can inhibit HSC self-renewal not only causing differen-
tiation but also leading the HSC to senescence [68–70]
and/or apoptosis [67], as it was demonstrated in the present
study. Attempting to answer whether ROS compromises
HSC self-renewal, we repeated the previous in vitro proto-
col but now focusing in ONS expression and founded that
ascorbic acid pretreatment (50 mg/mL) rescued ONS ex-
pression in HSC (data not shown).
Conclusion
The lifelong potential of HSCs has led to the hypothesis
that these cells could preserve both stemness function
and integrity. However, the present study provides new
evidence that cellular and molecular changes occur in
HSCs during aging. We investigated aspects of HSCs, in-
cluding self-renew, survival, differentiation, proliferation
and mobilization. We observed that aged mice exhibited
an increase in HSC number, myeloid skewing, DNA
damage, fewer quiescent cells and more cells in S/G2/M
phase of the cell cycle. Apoptosis and senescence may
have increased to control age-dependent alterations. The
scheme proposed in Fig. 6 emphasizes oxidative stress,
the impairment in antioxidant defenses and inflamma-
tion as the most important stimuli leading to age-related
changes observed in the bone marrow niche. Therefore,
our model contributes to a better understanding of age-
related changes in stem cells and may be helpful in
explaining the degenerative changes observed in organs
during aging.
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